VXM-65

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVXM-65

Drug Alias NameVXM-65

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsBrain Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVaximm AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaximm AG

Active IndicationsN/A

Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A